RubiconMD operates a digital eConsult platform that connects primary care clinicians with specialist insights to reduce unnecessary referrals and patient wait times. Launched in 2013 by Gil Addo and Carlos Reines, the platform offers quick access across more than 120 specialties and has partnered with major payors. The company aims to enable primary care to practice at the top of its license and to improve quality and affordability amid a shift toward value-based care. RubiconMD plans to leverage its data to deliver new product offerings for primary care clinicians and to expand its reach. Financially, the company has raised more than $40 million to date, including an $18 million Series C announced in this round. The new capital is intended to fuel ongoing growth and product development. RubiconMD provides a digital consult platform that connects primary care doctors with specialists. The company is New York-based and launched in 2013. RubiconMD announced a $13.8 million Series B round. The Series B was led by HLM Venture Partners and Optum Ventures and included Centene Corporation and Blue Ivy Ventures. The round also included all participating investors from its Series A. RubiconMD previously raised a $4 million Series A in mid-2016. RubiconMD operates a platform that allows primary care providers to request same-day eConsults from top medical specialists to improve patient care. Launched in 2013 and based in New York City, the company aims to unlock medical expertise by removing access barriers to specialty care. Its platform is intended to cut health care costs, save time, and streamline care so primary care providers can make faster, more informed recommendations. RubiconMD has an ongoing partnership with Zuckerberg San Francisco General Hospital and Trauma Center and is expanding its presence in California. The company recently added strategic hires — including Christine Peterson as Head of Customer Success in Berkeley — and expanded its advisory board with Hal Yee Jr., M.D., Ph.D. These moves, together with a direct investment from Heritage Provider Network, are intended to build California infrastructure and reach underserved populations on the West Coast. Launched in 2013 and based in New York City, RubiconMD offers eConsult, a digital messaging platform that connects primary care clinicians with specialists across more than 100 specialties and sub‑specialties. Clinicians use the app on any device and are algorithmically matched to a specialist, receiving educational responses usually within four hours or less. The platform is intended to create a collaborative medicine environment to help primary care providers make more informed patient care plans and to democratize medical expertise. The company has pursued opportunities to expand access in underserved regions, with a stated focus on improving specialty care access for Medi‑Cal enrollees in California, including rural areas. RubiconMD has participated in the athenahealth accelerator and is a graduate of Blueprint Health. The company recently announced a $750,000 investment from the California Health Care Foundation Innovation Fund and has raised over $6 million to date. RubiconMD operates an eConsult platform that connects primary care providers to a panel of specialists, allowing clinicians to upload images, labs, and studies and receive expert answers within hours. The system uses smart routing to identify the appropriate specialist and is designed to fit into primary care workflows to reduce unnecessary referrals, shorten patient wait times, and optimize care plans. The company has implemented its product with customers across twenty-six states. RubiconMD validated its model in a study finding that 97% of eConsults offered meaningful support to clinicians and 72% directly improved care plans. Launched in 2013 by two Harvard MBAs and a physician on the faculty at Harvard Medical School, the company recently closed a $4.0 million Series A to expand access and invest in product enhancements and data analytics.

Total raised

$38M

Funding rounds

6

Latest round

Series C

Latest activity

Mar 2020